Fruman DA - Search Results

1

Measurement of Calcineurin Phosphatase Activity in Cell Extracts.

Fruman DA, Pai SY, Klee CB, Burakoff SJ, Bierer BE. Fruman DA, et al. Methods. 1996 Apr;9(2):146-54. doi: 10.1006/meth.1996.0020. Methods. 1996. PMID: 8812656

2

Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

Bierer BE, Holländer G, Fruman D, Burakoff SJ. Bierer BE, et al. Curr Opin Immunol. 1993 Oct;5(5):763-73. doi: 10.1016/0952-7915(93)90135-f. Curr Opin Immunol. 1993. PMID: 7694595 Review.

3

Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors.

Juarez D, Buono R, Matulis SM, Gupta VA, Duong M, Yudiono J, Paul M, Mallya S, Diep G, Hsin P, Lu A, Suh SM, Dong VM, Roberts AW, Leverson JD, Jalaluddin M, Liu Z, Bueno OF, Boise LH, Fruman DA. Juarez D, et al. Among authors: fruman da. Cancer Res Commun. 2023 Dec 8;3(12):2497-2509. doi: 10.1158/2767-9764.CRC-23-0350. Cancer Res Commun. 2023. PMID: 37956312 Free PMC article.

4

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.

Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Toska E, Davids MS, Brown JR, Diana P, Stebbing J, Fruman DA, Kumar AP. Glaviano A, et al. Among authors: fruman da. Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6. Mol Cancer. 2023. PMID: 37596643 Free PMC article. Review.

5

The road less traveled: activating an oncogenic kinase.

Paul M, Fruman DA. Paul M, et al. Among authors: fruman da. Trends Pharmacol Sci. 2023 Oct;44(10):640-642. doi: 10.1016/j.tips.2023.07.005. Epub 2023 Aug 7. Trends Pharmacol Sci. 2023. PMID: 37553270 Free article.

6

Synthesis of a Complex Brasilicardin Analogue Utilizing a Cobalt-Catalyzed MHAT-Induced Radical Bicyclization Reaction.

Niman SW, Buono R, Fruman DA, Vanderwal CD. Niman SW, et al. Among authors: fruman da. Org Lett. 2023 May 19;25(19):3451-3455. doi: 10.1021/acs.orglett.3c01019. Epub 2023 May 4. Org Lett. 2023. PMID: 37141632 Free PMC article.

7

Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia.

Buono R, Alhaddad M, Fruman DA. Buono R, et al. Among authors: fruman da. Front Oncol. 2023 Apr 14;13:1162694. doi: 10.3389/fonc.2023.1162694. eCollection 2023. Front Oncol. 2023. PMID: 37124486 Free PMC article.

8

Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics.

Finicle BT, Eckenstein KH, Revenko AS, Anderson BA, Wan WB, McCracken AN, Gil D, Fruman DA, Hanessian S, Seth PP, Edinger AL. Finicle BT, et al. Among authors: fruman da. Nucleic Acids Res. 2023 Feb 28;51(4):1583-1599. doi: 10.1093/nar/gkad023. Nucleic Acids Res. 2023. PMID: 36727438 Free PMC article.

9

Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy.

Mohammad SN, Choi YS, Chung JY, Cedrone E, Neun BW, Dobrovolskaia MA, Yang X, Guo W, Chew YC, Kim J, Baek S, Kim IS, Fruman DA, Kwon YJ. Mohammad SN, et al. Among authors: fruman da. J Control Release. 2023 Feb;354:91-108. doi: 10.1016/j.jconrel.2022.12.048. Epub 2023 Jan 5. J Control Release. 2023. PMID: 36572154

10

Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition.

Vo TT, Herzog LO, Buono R, Lee JS, Mallya S, Duong MR, Thao J, Gotesman M, Fruman DA. Vo TT, et al. Among authors: fruman da. Sci Rep. 2021 Nov 4;11(1):21689. doi: 10.1038/s41598-021-00950-y. Sci Rep. 2021. PMID: 34737376 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page